Scientists have identified a role for inflammatory monocytes in the progression of amyotrophic lateral sclerosis (AML), indicating that these immune cells may represent a therapeutic target. Howard L. Weiner, the Robert L. Kroc Professor of Neurology at Brigham and Women’s Hospital, is the senior author of the study.
